The store will not work correctly when cookies are disabled.
2-(4-(2-(5-(4-fluorophenyl)-1,3,4-oxadiazol-2-ylthio)ethoxy)benzylidene)malononitrile
ID: ALA2296210
PubChem CID: 76320366
Max Phase: Preclinical
Molecular Formula: C20H13FN4O2S
Molecular Weight: 392.42
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: N#CC(C#N)=Cc1ccc(OCCSc2nnc(-c3ccc(F)cc3)o2)cc1
Standard InChI: InChI=1S/C20H13FN4O2S/c21-17-5-3-16(4-6-17)19-24-25-20(27-19)28-10-9-26-18-7-1-14(2-8-18)11-15(12-22)13-23/h1-8,11H,9-10H2
Standard InChI Key: SXRIVDRWVHHQAN-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
16.7813 -15.3093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5967 -15.3105 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0036 -14.6060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5962 -13.8999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7777 -13.9027 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3744 -14.6078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8208 -14.6062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3002 -15.2646 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.0784 -15.0121 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0773 -14.1938 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.2984 -13.9433 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.7941 -15.4063 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
21.4936 -14.9838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4776 -14.1668 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1771 -13.7444 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.8927 -14.1390 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9034 -14.9539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6182 -15.3484 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3187 -14.9259 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2999 -14.1047 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5846 -13.7139 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0348 -15.3196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7338 -14.8962 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4499 -15.2899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7166 -14.0792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7028 -13.2666 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.1627 -15.6836 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.5573 -14.6102 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
3 7 1 0
8 9 1 0
7 8 1 0
9 10 2 0
10 11 1 0
11 7 2 0
9 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
19 22 1 0
22 23 2 0
23 24 1 0
23 25 1 0
25 26 3 0
24 27 3 0
6 28 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 392.42 | Molecular Weight (Monoisotopic): 392.0743 | AlogP: 4.48 | #Rotatable Bonds: 7 |
Polar Surface Area: 95.73 | Molecular Species: NEUTRAL | HBA: 7 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 4.02 | CX LogD: 4.02 |
Aromatic Rings: 3 | Heavy Atoms: 28 | QED Weighted: 0.33 | Np Likeness Score: -1.97 |
References
1. Deora GS, Karthikeyan C, Moorthy NSHN, Rathore V, Rawat AK, Tamrakar AK, Srivastava AK, Trivedi P. (2013) Design, synthesis and biological evaluation of novel arylidine-malononitrile derivatives as non-carboxylic inhibitors of protein tyrosine phosphatase 1B, 22 (11): [10.1007/s00044-013-0528-1] |